Bal Pharma Ltd

BALPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹162 cr, stock is ranked 1,835
High RiskStock is 3.38x as volatile as Nifty
104.052.80 (+2.77%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹162 cr, stock is ranked 1,835
High RiskStock is 3.38x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
34.18
PB RatioPB Ratio
3.04
Dividend YieldDiv. Yield
0.91%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bal Pharma Limited is engaged in the manufacture and sale of pharmaceutical products. The Company’s business comprises of Active Pharmaceutical Ingredients (API), Finished Formulations, Ayurvedic, Research and Development.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021213.21226.02172.94251.672.803.80-12.224.74
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnApr 15, 2022

Bal Pharma Limited has informed the Exchange about Disclosure of large corporate | Download

Bal Pharma Limited has informed the Exchange about Disclosure of large corporate | Download

Outcome of Board Meeting 
Announced OnApr 13, 2022

Bal Pharma Limited has informed the Exchange about Board Meeting held on 13.04.2022 to inter alia allotment of equity shares upon conversion of warrants. | Download

Bal Pharma Limited has informed the Exchange about Board Meeting held on 13.04.2022 to inter alia allotment of equity shares upon conversion of warrants. | Download

Cash Dividend 
Ex. DateSep 16, 2021

Final • Div/Share: ₹ 1

See all events